Related Experiment Video
Updated: Jun 2, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Autocrine motility factor and its receptor expressions in human oral squamous cell carcinoma (SCC) cells
Y Niinaka1, S Oida, A Ishisaki
1KARMANOS CANC INST,TUMOR PROGRESS & METASTASIS PROGRAM,DETROIT,MI 48201. WAYNE STATE UNIV,DEPT RADIAT ONCOL,DETROIT,MI 48201. WAYNE STATE UNIV,DEPT PATHOL,DETROIT,MI 48201. UNIV TOKYO,FAC DENT,DEPT BIOCHEM,BUNKYO KU,TOKYO 113,JAPAN. UNIV TOKYO,FAC DENT,DEPT ORAL & MAXILLOFACIAL SURG,BUNKYO KU,TOKYO 113,JAPAN. TORIDE KYODO GEN HOSP,DEPT ORAL SURG,TORIDE,IBARAKI 302,JAPAN. GUNMA UNIV,SCH MED,DEPT ORTHOPAED SURG,MAEBASHI,GUMMA 371,JAPAN.
Abstract:
Autocrine motility factor (AMF) a tumor-secreted 55 kDa cytokine induces tumor cell motility by a signal transduction pathway mediated by interaction with its receptor (AMFR) a cell surface glycoprotein of 78 kDa (gp78). Here, AMF secreted by the metastatic LMF4 human oral squamous-cell carcinoma (SCC) cells, induced dose- and time-dependent morphological changes and chemotaxis of the producing cells. Expression of AMFR mRNA was associated with the metastatic ability of SCC cell variants. The data presented show for the first time that SCC cells produce AMF and express AMFR and the expression is related to their invasiveness and metastatic potentials.
Insights
Oral squamous-cell carcinoma (SCC) cells produce autocrine motility factor (AMF) and its receptor (AMFR). AMF and AMFR expression correlates with SCC cell invasiveness and metastatic potential.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Autocrine motility factor (AMF) is a cytokine secreted by tumors that promotes cancer cell motility.
- AMF interacts with its receptor, AMFR (gp78), initiating a signal transduction pathway.
- The role of AMF and AMFR in oral squamous-cell carcinoma (SCC) metastasis requires further elucidation.
Purpose of the Study:
- To investigate the production and expression of AMF and AMFR in human oral squamous-cell carcinoma (SCC) cells.
- To determine the relationship between AMF/AMFR expression and the metastatic potential of SCC cells.
Main Methods:
- Culturing of metastatic LMF4 human oral squamous-cell carcinoma (SCC) cells.
- Dose- and time-dependent induction of morphological changes and chemotaxis by secreted AMF.
- Analysis of AMFR mRNA expression in SCC cell variants with varying metastatic abilities.
Main Results:
- SCC cells were shown to secrete AMF.
- Secreted AMF induced dose- and time-dependent morphological changes and chemotaxis in the producing SCC cells.
- AMFR mRNA expression was significantly associated with the metastatic capacity of SCC cell variants.
Conclusions:
- Human oral squamous-cell carcinoma (SCC) cells produce both AMF and its receptor, AMFR.
- The expression of AMF and AMFR in SCC cells is directly related to their invasiveness and metastatic potential.
- These findings highlight AMF/AMFR signaling as a potential therapeutic target for oral cancer metastasis.
Related Concept Videos
Mitogens and the Cell Cycle
Cell Migration
Cancer Cell Migration through Invadopodia
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Microtubules in Cell Motility
